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Abstract
Background: Chronic endometritis is a histopathologic diagnosis characterized by
endometrial inflammation rich in plasma cells. Through examination of this disease, we
hope to further elucidate the meaning of its diagnosis and whether or not it should be
more carefully considered when examining specimens.
Methods: A retrospective chart and slide review was conducted that focused on the
collection of clinical data and the examination and description of previous tissue samples
from endometrial biopsies. A total of 94 chronic endometritis cases and 99 controls were
identified. All statistical analyses were conducted using SAS version 9.1.
Results: Women with chronic endometritis were more likely to be within 41-50 year of
age (39/95, 41.1%), with 65.3% of cases in the 31-40 and 41-50 age categories (23/95,
39/95). They were also more likely to be perimenopausal (42/92, P-value 0.0015) and
multiparous (79.1%, P-value 0.1358). Additionally, hormone use was found to be
significantly associated with endometritis (P-value 0.0299). No specific symptoms were
found to correlate with chronic endometritis. Our study confirmed that the presence of
lymphocytes (P-value <0.0001), neutrophils (P-value 0.0029), and macrophages (P-value
0.0048) are associated with endometritis along with epithelial change/metaplasia (P-value
0.0595).
Discussion: Our study has helped to better understand the demographics of endometritis
and its clinical presentation; but as always, more studies are needed to further elucidate
the implications of this disease for women.

Introduction
Chronic endometritis is a histopathologic diagnosis characterized by endometrial
inflammation rich in lymphocytic cell infiltrates. While the diagnostic criteria for
chronic endometritis remains controversial, it is generally agreed upon that the presence
of plasma cells within the substance of the stroma is the most useful criteria for diagnosis
(1, 2, 3, 4, 5). While this is true, a variety of different features can alert the pathologist to
the possible presence of chronic endometritis. Disturbances in normal growth and
maturation (focal ares that are out of cycle with other areas), superfical mucosal stromal
edema, stromal breakdown, and characteristic spindle cell alteration of the stroma,
especially around glands, are all other morphological features that can be seen with
chronic endometritis (2, 3, 4, 5, 6, 7).

Plasma cell identification can often be difficult and problematic in the diagnosis
of chronic endometritis. Because stromal cells often resemble plasma cells, and vice
versa, it has been documented that plasma cells can be unreliable in diagnosising chronic
endometritis (3, 5). Because of this, ancillary studies may aid in establishing the
diagnosis. Syndecan-1 (CD138) is just such a study. It is a cell surface marker that is
expressed on plasma cells, and through immunohistochemical means, it has proven to be
an effective adjunct in the identification of plasma cells and the diagnosis of chronic
endometritis (2, 5).

In addition to plasma cells, the presence and location of lymphocytes may aid in
the diagnosis. Lymphocytes are considered a normal component of endometrial stroma
(3, 5, 8). Leukocytes generally account for 10% of stromal cells in normal proliferative

and early secretory phases. These number increase to well over 20% in the mid and late
secretory phase (3). The most predominate lymphocytes include T lymphocytes,
macrophages, and natural killer cells (3, 5). These cells are generally found within the
stratum basalis where they form lymphoid aggregates, in the stratum functionalis where
they are scattered singly and in small aggregates around glands and blood vessel, and
lastly in an intraepithelial position and within glandular lumina (3). B lymphocytes are a
rare cell to be found in the endometrium (3, 5). They account for fewer than 1% of all
endometrial leukocytes and are found as lymphoid aggregates in the stratum basalis as
well as scattered individually throughout the superficial stratum functionalis (3, 5).

While endometritis can be an incidential finding on endometrial biopsy, it has
also been associated with a number of entities. There has been a relationshiop noted
between gonorrhea, Chlamydia, bacterial vaginosis, and mycoplasma. Furthermore, in
some cases, chronic endometritis has been suggested to be a low-grade form of pelvic
inflammatory disease (4, 6, 7, 9, 10, 11, 12). In others, infection does not seem to play a
role. It has been variably observed with inflammation associated with structural
abnormalities (polyps, submucosal leiomyomata, prolapse). It is also often found in
postpartum and post-abortal endometria (6).

From the above, it is evident that a variety of studies have addressed different
aspects of chronic endometritis. Current knowledge is based on studies investigating the
etiology (gonorrhea, Chlamydia, bacterial vaginosis, or idiopathic infections),
correlations with pelvic inflammatory disease, and whether or not these are different
stages of the same disease or separate entities. Additionally, further investigations have

revealed the utility and effectiveness of treatments for chronic endometritis and attempted
to clarify the pathologic features, epidemiology, and correlation with clinical findings.

Unfortunately, many of the studies examining the pathology of endometritis have
either focused solely on the histopathology or used very small cohorts when trying to
correlate histopathology with clinical findings. In addition, the epidemiology of
endometritis is unclear and currently thought to have no specific predilections in almost
all demographic categories. Moreover, there is little in the way of recent updates of the
epidemiology of this condition. Current knowledge is fairly well developed in the
presentation, common clinical signs and symptoms, and histopathology independently,
but crucial data incorporating all of these aspects is lacking.

The meaning and correlations of diseases related to chronic endometritis have
been only loosely examined and there is currently no clear and large sample that
combines both the histopathology and clinical findings in a statistically significant and
clear manner. In addition, the finding of chronic endometritis in both the Hispanic and
Native American populations has not been represented. Using an expanded population
with a tight linkage between clinical and specific pathologic features will develop a better
understanding of multiple facets of the disease including incidence, prevalence, and
outcome. We hypothesis that thorough examination of chronic endometritis, its
associated histopathologic findings, and clinical history will help to further elucidate the
meaning of this diagnosis and whether or not there it should be more carefully considered
when examining specimens.

The aims of the study include: updating current information about the
epidemiology, clinical presentation and outcome of patients with chronic endometritis,
expanding on and/or confirming the currently agreed upon histopathologic findings of
chronic endometritis, and correlating the clinical and histopathologic findings in a more
diverse patient population than has been previously reported.
Methods
With permission from our institutional review board, we undertook a
retrospective chart and slide review that focused on the collection of clinical data and the
examination and description of previous tissue samples. A total of 194 cases were
identified. Ninety-five women with a diagnosis of chronic endometritis and 99 women of
similar age and menstrual status were identified. This was accomplished by searching
Power Path®, our pathology electronic database, for previous endometrial biopsies from
2004 to 2007 at The University of New Mexico Hospital and associated clinics, for cases
of chronic endometritis in women and women with endometrial biopsies without the
diagnosis of chronic endometritis. The diagnosis of chronic endometritis was based on
standard criteria available at the time of diagnosis. Cases that were identified as having
missing clinical data or scant tissue on endometrial biopsies were included in an effort to
preserve random sampling. Cases were excluded if the endometrial samples were not
clear biopsies, were part of large resections due to carcinoma, or were not clear cases of
endometritis. Once the patients and biopsies were identified unique identifiers were
assigned to each case. Subsequently, one investigator undertook a chart review of Power
Chart, our electronic medical record system. A variety of information was collected
including: demographics and clinical features of endometritis.

At the same time, a separate additional investigator collected and examined
previously prepared and stored hematoxylin and eosin stained tissue slides from the
cases. A number of defined histologic parameters were evaluated for including variables
such as cell types, degrees of inflammation, and presence of various types of metaplasia.
Lastly, the data was combined in a spreadsheet including the clinical characteristics and
analyzed for any relationships or significant findings.
All statistical analyses were conducted using SAS version 9.1. Chi-square tests
were used in the analysis of dichotomous or categorical variables. When expected cell
frequencies were <5, the Fisher exact test was used.
Results
The mean age of all patients was 46 with a range from 21-86 years of age (Table
1). In terms of ethnicity, the majority (42%) of patients were Hispanic, followed by
Whites (26%) and others. Native American (7%), Asians (3%), and African Americans
(1%) were represented in much smaller numbers (Table 2). Premenopausal women
represented the largest number of individuals (43%) in the overall sample (Table 3). In
addition, 79.8% of the women in our study had been pregnant >1 time. Lastly, out of the
entire study population, 24.1% women were using some form of hormones (oral
contraceptive pills, hormone replacement therapy, etc) at the time of biopsy. (Table 4).
When considering age, a preponderance of endometritis cases occurred in the 4150 age category (39/95, 41.1%), with 65.3% of cases in the 31-40 and 41-50 age
categories (23/95, 39/95), a handful of cases fell in the 21-30 and 51-60 age categories
(13/95, 12/95), and few in the 71-80 and 81-90 categories (2/95, 2/95). (Table 1).

Given our sample population, endometritis was very prevalent in the Hispanic
population. Forty-two percent of endometritis cases were in patients of Hispanic
ethnicity (40/95), followed by 26.3% of Whites (25/95), 20% others (19/95), 7.4% Native
Americans (7/95), 3.2% Asians (3/95), and 1.1% African American (1/95) (Table 2).
Despite these findings, no ethnic category was significantly associated with endometritis
(P-value 0.3665).
As mentioned above, the bulk of both cases and controls fell within the
premenopausal category (82/191; missing data for 3 cases). Interestingly though, the
greater part of the endometritis cases were found within the perimenopausal group.
There were a total of 42/92 cases considered to be perimenopausal compared to 21/99
controls (45.7% versus 21.2%; P-value 0.0015). (Table 3).
When examining parity and hormone use, an increased number of pregnancies
and hormone use were both associated with the occurrence of chronic endometritis,
although hormone use was the only statistically significant value. Multiparous women
were more likely to have the diagnosis of endometritis then their nulliparous and
primiparous counter parts (79.1% versus 4.4% and 16.5; missing data for 4 cases; P-value
0.1358). When this data is compared to the controls, 80.5% were mutiparous, 9.2%
primiparous, and 10.3% nulliparous (missing data for 12 controls). Additionally, 31.1%
of the endometritis cases were using some form of hormonal contraception at the time of
biopsy, compared to 17.5% of the controls (missing data for 5 cases; P-value 0.0299)
(Table 4).
Data on symptoms included intermenstrual vaginal bleeding, lower abdominal
pain, dysmenorrhea, menorrhagia, and menometrorrhagia. When examining these

symptoms individually, no single symptom was significantly linked with endometritis.
Although, the diagnosis of endometritis was most closely associated with
menometorrhagia, 44% of endometritis cases experienced heavy vaginal bleeding with
and without their period contrasted with only 33.3% of controls (missing data for 4 cases;
P-value 0.1326). Intermenstrual vaginal bleeding was the next most closely related
symptom with endometritis, followed by lower abdominal pain, menorrhagia, and
dysmenorrhea. Endometritis cases experienced intermenstrual vaginal bleeding 62.6% of
the time, lower abdominal pain 25.3% of the time, and menorrhagia 61.5% of the time.
On the other hand, 67.7% of controls experienced intermenstrual vaginal bleeding, 22.2%
experienced lower abdominal pain, and 60.6% experienced menorrhagia. Surprisingly,
dysmenorrhea was found to correspond with the control group more so than the cases
(28.3% versus 15.4%, P-value 0.0323). (Table 5).
Different findings were discovered when symptoms were examined in
combination. The most prevalent combination of symptoms in the endometritis cases
were intermenstural vaginal bleeding, menorrhagia, and menometorrhagia (21/91, data
missing in 4 cases). For the controls, the most prevalent symptom was intermenstrual
vaginal bleeding by itself (19/99). When symptom combinations in the cases were
compared to the controls, the endometritis cases experienced no symptoms roughly twice
as often as the controls (14.3% versus 8.1%). Moreover, it was three and a third times
more likely for the controls to experience intermenstrual vaginal bleeding, dysmenorrhea,
menorrhagia, and menometorrhagia in combination than the cases (10.1% versus 3.3%).
(Table 5).

Form of treatment and resolutions of symptoms were categories that were also
looked at. Through the data analysis, it was discovered that resolution of symptoms were
greater for those who received treatment (antibiotics or surgery) versus those who
received no treatment in both cases (56/61 versus 7/12, missing data for 22 cases; P-value
0.0011) and controls (37/38 versus 24/35, missing data for 26 controls; P-value 0.0009).
Likewise, surgery was far superior in terms of resolution of symptoms than antibiotics in
the cases, as would be expected (8/11 versus 48/50, missing data for 22 cases). (Table 6).
There were a total of 37 control cases that were found to have normal
endometrium (missing data for 20 controls). Of these 37 patients, 3 had plasma cells
present. Two of these individuals had 1 plasma cell present, while one individual had 2
plasma cells present. There were 42 abnormal endometrium cases found within the
control population; and of these, 12 were found to have plasma cells present. Eight of
these controls had less than 5 plasma cells present, while 4 were found to have any where
from 16 to 39 plasma cells within the tissue. (Table 7).
The phase of cycle was analyzed to determine if there was a difference in this
grouping when plasma cells were present and not present. When normal endometrium
was examined, it was found that 63.2% had little or no plasma cells present while 36.8%
were abundant in plasma cells. Compare this to 62.7% abnormal endometrium with very
little or no plasma cells and 37.3% abundant plasma cells (missing data for 1 case; Pvalue 0.9684). Hence, this analysis showed there was no difference.
In terms of histology, both cases and controls were scrutinized for the presence of
plasma cells within the endometrial tissue. This information was then cross linked with
the duration of symptoms. It was found that the majority of endometritis cases (52.6%),

had symptoms for <1 year but >1 month. Of these cases, 87.8% had plasma cells present
in the endometrium. When only endometritis cases with identified plasma cells were
examined, 53.7% of these patients experienced symptoms for <1 year but >1 month.
When compared to controls, this data was not statistically significant (missing data for 17
cases; P-value 0.4086). The bulk of the control patients also experienced symptoms for
<1 year but >1 month (56.2%); but, only 22% of these cases had plasma cells present.
Also, 64.3% of the controls with identified plasma cells fell within the <1 year, >1 month
category (missing data for 26 controls). (Table 7).
In order to further investigate the types of immune cells found in tissue with the
diagnosis of chronic endometritis, we looked at the occurrence of lymphocytes,
neutrophils, macrophages, and eosinophils in the presence of plasma cells for cases and
controls. Lymphocytes were the most significantly associated with plasma cells and the
diagnosis of endometritis (data missing for 20 controls; P-value <0.0001). At total of 148
biopsies (84 cases, 64 controls) had identified plasma cells. The vast majority of cases
had moderate to florid plasma cells throughout (62/95), whereas there were only 12
controls that were identified with large numbers of plasma cells present. Most controls
(67/79) consisted of only mild or no plasma cells within the endometrium. In addition,
macrophages and neutrophils were also found to coincide with the presence of plasma
cells (P-value 0.0029; P-value 0.0048; data missing for 20 controls in both). Eosinophils,
on the other hand, were not associated with the diagnosis of endometritis (P-value
0.1668; missing data for 20 controls). (Table 8).
Lastly, several histological features including spindled cells, epithelial
changes/metaplasia, and vasculitis within the endometrium were examined and their

occurrence with plasma cells noted. Within the cases, 50% were noted to have spindled
cells. Regrettably, this finding was not significant (P-value 0.2346) in that 66.7% of the
identified control also had spindled cells present. Epithelial change/metaplasia was
exhibited in 49.5% of cases compared to only 7.2% of controls (P-value 0.0595).
Vasculitis, conversely, was not found in either the cases or controls. (Table 9).
Discussion
Many interesting inferences were revealed through retrospective examination of
clinical and histopathological data of women who underwent endometrial biopsies with
and without evidence of chronic endometritis.
In terms of the demographic make up of women who are given the diagnosis of
endometritis in our study, many were found to be within the age range of 31-50 years of
age and were perimenopausal. These findings may be due to the irregular menstrual
cycle of perimenopause. The proliferative phase of the menstrual cycle has been
previously associated with plasma cell endometritis (12); and since womens’ cycles tend
to lengthen with longer proliferative phases during perimenopause, this may be one
reason for our findings. Research done by Crum et al. demonstrated that 2/3 of women
under 40 who had recently been pregnant (postpartum or post-abortive), received the
diagnosis of endometritis. Furthermore, the majority of women between 41 and 50
presented with unexplained uterine bleeding or a history of intrauterine device use (6).
Although these identifiers were not specifically looked at in our study, they could also
play into the reason for the high number of endometiritis diagnosis in this group.
In addition, significantly more women in our endometritis group were
multiparous compared to those who were in the control. It is not clear why parity may

increase the likelihood of chronic endometritis. Possible reasons may include greater
disturbances and changes to the endometrium, which make it more susceptible to
infection, damage, or irritation leading to the recruitment of plasma cells and
lymphocytes.
Unlike studies in the past, our study found hormone use to be significantly
associated with endometritis. According to Ross et al. oral contraceptive pills do not
increase the risk of endometritis, but do appear to make infections more likely to be
asymptomatic (4). Eckert et al goes further by stating current oral contraceptive use does
not have any significant associate with endometritis (12). The difference in our finding
may be due to the fact that we included all hormone use, not just oral contraceptive pills.
Women who were receiving Depo-lupron, hormone replacement therapy, etc were
considered in the hormone use category.
Interestingly, no specific clinical symptom was associated with histologic
endometritis in our study. Wiesenfeld et al. and Eckert et al. had similar findings (10,
11). Nevertheless, they did determine that abdominal pain during physical exam was
associated with chronic endometritis (10, 11, 12). Even more surprisingly, our study
showed women with the diagnosis of chronic endometritis were more likely to be
asymptomatic that the controls. This may have something to do with Ross et. al finding
of oral contraception making endometritis more likely to be asymptomatic, given that a
large number of our endometritis population were using hormones at the time of biopsy.
Also, a number of our asymptomatic endometritis cases were discovered following
routine pap smear. Unfortunately, our study did not investigate the spatial relationship
with pregnancy and biopsy, but it could be these samples were obtained during pregnancy

or following birth. Consequently, the high number of plasma cells could be due to
pregnant or post-partum endometrium.
Clinical-pathological studies that have looked at density of plasma cell infiltrate
and the severity of clinical symptoms have not been able to show an association between
the two (1). Our study confirms these previous findings. When looking at duration of
symptoms and the amount of plasma cells present, we were unable to show that patients
who had a large number of plasma cells found within the endometrium had a longer
duration of symptoms.
According to our results, there are several additional features other than just
plasma cells that signify chronic endometritis, or at the very least are associated with its
diagnosis. Immune cells that were shown to correlate with endometritis include
lymphocytes, neutrophils, and macrophages. These findings are similar to other studies
(4,6). It was further established that spindle cell alteration of the stroma and epitheliatal
change/metaplasia coincide with endometritis (6).
One major limitation of our study was the small number of endometritis cases
with corresponding clinical symptoms available for examination. While we were able to
gather 95 cases from 2004 to 2007, many samples were missing the corresponding
clinical data. Also, endometrial biopsies for the controls were included despite
insufficient tissue for examinination in order to preserve the random sample. This method
left many cases with absent histological data. In both cases, during analysis, this data
was set to missing, which greatly reduced our sample size and ability to make inferences
from the data and to develop statistical significance.

In conclusion, our findings have helped to update information about the
epidemiology and clinical presentation of chronic endometritis. We have also confirmed
the currently agreed upon histopathologic findings of this entity along with correlating
the clinical and histopathologic findings in a more diverse patient population than has
been previously reported. Unfortunately, given the lack of power in our study, we were
unable to provide more information regarding whether or not endometritis should be
more carefully considered when examining specimens. As always, future studies with a
similar focus, but larger sample size, are needed to further elaborate on the findings of
endometritis.
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Table 1: Patient Ages
Age Range Case

Control

21-30

13

0

31-40

23

19

41-50

39

49

51-60

12

21

61-70

4

6

71-80

2

2

81-90

2

2

Total

95

99

Table 2: Patient Ethnicities
Ethnicity

Case

Control

White

25

32

African American

1

1

Hispanic

40

42

Asian

3

0

Native American

7

3

Other

19

21

Total

95

99

Menstrual Status

Case

Control

Pre-Menopausal

33

49

Peri-Menopausal

42

21

Post-Menopausal

17

29

Total

92

99

Table 3: Menostrual Status

Table 4: Hormone Use
Hormone Case
Use

Control pvalue

Yes

28

17

No

62

80

Total

90

97

0.029

Table 5: Symptoms: Menometrorrhagia (A), Intermentsrual Vaginal Bleeding (B), Lower
Abdominal Pain (C) , Dysmenorrhea (D), Menorrhagia (E), No symptoms and 4
Symptoms.
(A)

(B)

(C)

(D)

(E)

No Symptoms

A+B+D+
E

40

57

23

14

56

13

3

Control 33

67

22

28

60

8

10

Case

Table 6: Forms of Treatment
Treatment

Case

Control

Antibiotics

8

24

Surgery

48

37

Table 7: Duration of Symptoms and Frequency of Plasma Cells
Duration of
Symptoms

Cases w/o
plasma cells

Cases w/
plasma cells

Controls w/o
plasma cells

Controls w/
plasma cells

< 1 Month

1

13

6

1

< 1 Year

5

36

32

9

> 1 Year

5

18

21

4

Table 9: Cells types associated with Endometritis
Lymphocytes Neutrophils

Macrophages Eosinophils

Cases

84

48

35

38

Controls

64

21

11

31

Table 9: Histologic features associated with Endometritis
Group

Spindeled
Stroma

Epithelial
Change

Vasculitis

Case

41

38

0

Control

5

5

0
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